Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.75 |
| ▸ | PNP | P00491 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.57 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.57 |
| ▸ | PIM1 | P11309 | 1/20 | 0.57 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.57 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.57 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.57 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23982423 | 1.00 | HIF1A (0.75) | HIF1APNPLMNATP53HTT | |
| SCHEMBL2048956 | 1.00 | HIF1A (0.75) | HIF1APNPLMNATP53HTT | |
| SCHEMBL98134 | 1.00 | HIF1A (0.75) | HIF1APNPLMNATP53HTT | |
| SCHEMBL2408903 | 1.00 | HIF1A (0.75) | HIF1APNPLMNATP53HTT | |
| SCHEMBL14440926 | 0.92 | HIF1A (0.64) | HIF1ASMN1; SMN2 | |
| Deoxyinosine SCHEMBL2000526 | 0.86 | HIF1A (0.73) | HIF1APNPLMNATP53HTT | |
| Deoxyinosine SCHEMBL24307 | 0.86 | HIF1A (0.73) | HIF1APNPLMNATP53HTT | |
| Deoxyinosine SCHEMBL324457 | 0.86 | HIF1A (0.73) | HIF1APNPLMNATP53HTT | |
| Deoxyinosine SCHEMBL7191121 | 0.86 | HIF1A (0.73) | HIF1APNPLMNATP53HTT | |
| Deoxyinosine SCHEMBL5982293 | 0.86 | HIF1A (0.73) | HIF1APNPLMNATP53HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9290533-B2 | β-L-2′-deoxy-nucleosides for the treatment of hepatitis B | NOVARTIS AG (CH) | 2016-03-22 | — | — | US | disclosed |